DALLAS, TX--(Marketwire - August 11, 2009) -
Highlighted Links |
Metiscan Website |
Follow Metiscan on Twitter |
Metiscan anticipates that share purchases shall be made from time to time, depending upon market conditions. Shares may be purchased in the open market, including through block purchases, or through privately negotiated transactions. Metiscan does not intend to repurchase any shares from directors, officers or other affiliates of Metiscan. The repurchase program does not obligate Metiscan to acquire any specific number of shares and may be discontinued at any time.
Metiscan intends to fund the repurchases with available cash. The repurchase program is expected to be in effect until the approved amount of shares has been repurchased each year.
About Metiscan, Inc.
Metiscan, Inc. is a holding company focused on growing its organization by making key acquisitions and developing companies and emerging technologies. Previously, Metiscan had been focused on healthcare related businesses and is currently pursuing acquisitions and opportunities related to healthcare and non-healthcare mobile products and services.
Metiscan operates FirstView EHR, Inc., a wholly owned subsidiary, that provides end-to-end IT services for diagnostic imaging facilities including web based electronic healthcare records (EHR), workflow efficiency, PACS administration, long-term archiving, professional IT services and strategic consulting. Metiscan operates Schuylkill Open MRI, Inc., a majority owned subsidiary that is an independent diagnostic testing facility (IDTF) providing Magnetic Resonance Imaging (MRI) services. Metiscan also operates Taptopia, Inc., a wholly owned subsidiary that provides design and development services for Smartphone platforms. Metiscan also operates Shoreline Employment Services, Inc., a wholly owned subsidiary that provides employment services and benefits to all of Metiscan's subsidiaries and intends to provide such services to third parties in the future.
Safe Harbor Statement: Certain of the statements made in this press release
constitute forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933 and Section 27E of the Securities Act of 1934.
Such forward-looking statements involve known and unknown risks,
uncertainties and other unknown factors that could cause Metiscan's actual
results to be materially different from the historical results or from any
future results expressed or implied by such forward-looking statements.
Statements contained in this release that are not historical facts may be
deemed to be forward-looking statements. In addition to statements that
explicitly describe such risks and uncertainties, readers are urged to
consider statements labeled with the terms "believes," "belief," "intends,"
"anticipates" or "plans" to be uncertain and forward-looking. The Company
does not intend to update any of the forward-looking statements after the
date of this release to conform these statements to actual results or to
changes in its expectations, except as may be required by law.
Investor Relations:
Contact:
StockOrange
Dylan Yarter
President
Voice: 214.872.6570
Email: Email Contact
Web: www.stockorange.com